GMP Audit Services
Reliable Audit Solutions to Ensure Global Compliance and Safeguard Your Supply Chain
Comprehensive GMP Audit Services for End-to-End Supply Chain Compliance
Comprehensive GMP Audit Services for End-to-End Supply Chain Compliance
We are reputable provider of 17 years of experience in GMP audits to ensure products meet industry standards and quality standards. Our experienced team conducts GMP audits globally, assessing a pharma company’s control over processes, facilities, and QMS, including API, intermediates, raw materials, warehouses, and packaging facilities. Trust Zenovel for reliable GMP audits that help maintain excellence in pharmaceutical manufacturing.
- Third Party Audit Services
We conducts third-party GMP audits using experienced auditors to assess a supplier’s compliance with regulatory standards, including detailed documentation review, on-site inspections, staff interviews, and comprehensive reporting to ensure adherence to Good Manufacturing Practice guidelines.
We can meet all of your supply-chain auditing needs.
We proactively assist in alleviating audit burdens
We understand the demands and constraints placed on pharmaceutical firms, as well as the pressure their suppliers face from audits. This inspired us to develop a strategy that benefits all stakeholders while offering a premium audit service.
Our framework provides elite audit services tailored to the demands of pharmaceutical firms’ effectively addressing challenges in supplier auditing. We prioritize adherence to standards, regulations, and impartiality, avoiding conflicts of interest and supplier-customer interactions.
- Our Audit Framework
We streamline auditing process by identifying top-tier auditing firms and auditors, coordinating all stakeholders to align audit schedule with auditor and sponsor timelines.
Upon contract agreement, we promptly initiate audit planning, scheduling audit days based on the auditor and sponsors deadlines. After scheduling, the company seeks competent auditors and qualified teams to effectively handle and execute the audit.
Utilize our complete audit life cycle management services to streamline your supplier audit, covering planning, execution, reporting, and CAPA follow up, allowing you to efficiently manage and conclude audits for your suppliers. From here we take care of audit from beginning to the end.
- Joint Audit
We conducts third-party GMP audits using experienced auditors to assess a supplier’s compliance with regulatory standards, including detailed documentation review, on-site inspections, staff interviews, and comprehensive reporting to ensure adherence to Good Manufacturing Practice guidelines.
We aim to offer the most feasible choice, providing shared costs and tailored reports at the best possible price for you
We provide Joint Audit Services, a collaborative auditing method where multiple parties collaborate. This approach ensures comprehensive assessments, optimizes efficiency, reduces duplication, and enhances transparency. It leads to improved compliance and quality. Trust Zenovel for expertly managed joint audit services, fostering cooperation and driving excellence in regulatory compliance.
-
What can you anticipate from our All-in-One,
Zenovel Solution?
- Why Choose Zenovel ?
- Audit Spectrum
We are qualified to audit a wide range of international manufacturers of pharmaceutical drugs and to all applicable regional and global compliance requirements.
- Unanimity
Auditors maintain a high level of impartiality in their evaluations, assessing sponsors’ specific requirements and communicating them to the auditors using unbiased standards
- Maintaining Confidentiality
The audit sponsors, auditors, and sponsors are all subjected to strict confidentiality conditions, including through NDAs or CDAs, to ensure the integrity of all information.
- No Competing Interest
The EMA guidelines mandate that auditors and sponsors must have no commercial connections, which auditors thoroughly examine during the audit process to ensure regulatory compliance.
- Tailored Reports
Each sponsor receives a detailed report tailored to their interests and specific updates based on their criteria.
- Global Services
We offer global audit services with native auditors, ensuring comprehensive coverage and adherence to international standards in any country.
People Also Ask (FAQs)
A Good Manufacturing Practice (GMP) audit is a systematic evaluation of pharmaceutical manufacturing processes, facilities, documentation, and quality systems to ensure compliance with regulatory guidelines and industry standards. GMP audits help verify that medicines are consistently produced and controlled according to quality requirements.
GMP audits help pharmaceutical companies identify compliance gaps, improve quality systems, and ensure adherence to international regulatory standards. They also support supply chain reliability and help organizations prepare for inspections by regulatory authorities such as the FDA, EMA, and WHO.
Zenovel offers a variety of GMP audit services including third-party supplier audits, joint audits, remote audits, gap audits, and vendor qualification audits. These audits evaluate manufacturing facilities, quality systems, and operational processes to ensure compliance with regulatory expectations.
The GMP audit process usually includes audit planning, documentation review, on-site inspection of facilities, interviews with staff, evaluation of quality management systems, and preparation of detailed audit reports. Corrective and preventive actions (CAPA) are then recommended to address identified compliance gaps.
Zenovel provides comprehensive GMP audit support through experienced auditors who evaluate pharmaceutical facilities, supply chains, and quality systems. Their services cover the entire audit lifecycle, including planning, execution, reporting, and CAPA follow-up to help companies maintain global compliance and operational excellence.
Blogs and news
Our Latest Article
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
